Ashkenazi A, Matro R, Shaw J W, Abbas M A, Silberstein S D
Department of Neurology, Thomas Jefferson University, 111 South 11th Street, Suite 8130, Philadelphia, PA 19107, USA.
J Neurol Neurosurg Psychiatry. 2008 Apr;79(4):415-7. doi: 10.1136/jnnp.2007.124420. Epub 2007 Aug 6.
To determine whether adding triamcinolone to local anaesthetics increased the efficacy of greater occipital nerve block (GONB) and trigger-point injections (TPIs) for transformed migraine (TM).
Patients with TM were randomised to receive GONB and TPIs using lidocaine 2% and bupivacaine 0.5% + either saline or triamcinolone 40 mg. We assessed the severity of headache and associated symptoms before and 20 minutes after injection. Patients documented headache and severity of associated symptoms for 4 weeks after injections. Changes in symptom severity were compared between the two groups.
Thirty-seven patients were included. Twenty minutes after injection, mean headache severity decreased by 3.2 points in group A (p<0.01) and by 3.1 points in group B (p<0.01). Mean neck pain severity decreased by 1.5 points in group A (p<0.01) and by 1.7 points in group B (p<0.01). Mean duration of being headache-free was 2.7+/-3.8 days in group A and 1.0+/-1.1 days in group B (p = 0.67). None of the outcome measures differed significantly between the two groups. Both treatments were well tolerated.
Adding triamcinolone to local anaesthetics when performing GONB and TPIs was not associated with improved outcome in this sample of patients with TM.
确定在局部麻醉药中添加曲安奈德是否能提高枕大神经阻滞(GONB)和触发点注射(TPI)治疗转化型偏头痛(TM)的疗效。
将TM患者随机分为两组,分别接受使用2%利多卡因和0.5%布比卡因加生理盐水或40mg曲安奈德的GONB和TPI。我们在注射前和注射后20分钟评估头痛及相关症状的严重程度。患者记录注射后4周内的头痛情况及相关症状的严重程度。比较两组症状严重程度的变化。
共纳入37例患者。注射后20分钟,A组平均头痛严重程度降低3.2分(p<0.01),B组降低3.1分(p<0.01)。A组平均颈部疼痛严重程度降低1.5分(p<0.01),B组降低1.7分(p<0.01)。A组平均无头痛持续时间为2.7±3.8天,B组为1.0±1.1天(p = 0.67)。两组间的任何一项结局指标均无显著差异。两种治疗的耐受性均良好。
在对TM患者进行GONB和TPI时,在局部麻醉药中添加曲安奈德与本样本患者的预后改善无关。